Integrated serum proteomics and autoantibody analyses reveal a biomarker signature predictive of flare during biologic tapering in rheumatoid arthritis
Francisco Javier Blanco, Patricia Quaranta, Pablo Domínguez-Guerrero, Valentina Calamia, Patricia Fernández‐Puente, Rocío Paz-González, Vanesa Balboa-Barreiro, Diana M. Noriega-Cobo, Laura Galindo, Belén Acasuso, Natividad Oreiro, Ricardo Rojo, L. Lourido, Cristina Ruíz‐Romero
This paper identifies a biomarker signature combining serum proteins and autoantibodies to predict flare risk during biologic tapering in rheumatoid arthritis.
RMD Open · Jul 1, 2026Peer-reviewedMolecular Biology